1: Vior NM, Olano C, García I, Méndez C, Salas JA. Collismycin A biosynthesis in Streptomyces sp. CS40 is regulated by iron levels through two pathway-specific regulators. Microbiology (Reading). 2014 Mar;160(Pt 3):467-478. doi: 10.1099/mic.0.075218-0. Epub 2013 Dec 18. PMID: 24353310.
2: Kawatani M, Muroi M, Wada A, Inoue G, Futamura Y, Aono H, Shimizu K, Shimizu T, Igarashi Y, Takahashi-Ando N, Osada H. Proteomic profiling reveals that collismycin A is an iron chelator. Sci Rep. 2016 Dec 6;6:38385. doi: 10.1038/srep38385. PMID: 27922079; PMCID: PMC5138588.
3: Pang B, Liao R, Tang Z, Guo S, Wu Z, Liu W. Caerulomycin and collismycin antibiotics share a trans-acting flavoprotein-dependent assembly line for 2,2'-bipyridine formation. Nat Commun. 2021 May 25;12(1):3124. doi: 10.1038/s41467-021-23475-4. PMID: 34035275; PMCID: PMC8149447.
4: Choi H, Lee W, Kim E, Ku SK, Bae JS. Inhibitory effects of collismycin C and pyrisulfoxin A on particulate matter-induced pulmonary injury. Phytomedicine. 2019 Sep;62:152939. doi: 10.1016/j.phymed.2019.152939. Epub 2019 Apr 23. PMID: 31100678.
5: Garcia I, Vior NM, González-Sabín J, Braña AF, Rohr J, Moris F, Méndez C, Salas JA. Engineering the biosynthesis of the polyketide-nonribosomal peptide collismycin A for generation of analogs with neuroprotective activity. Chem Biol. 2013 Aug 22;20(8):1022-32. doi: 10.1016/j.chembiol.2013.06.014. Epub 2013 Aug 1. PMID: 23911584.
6: Kim E, Ku SK, Yang S, Lee BS, Kim GJ, Choi H, Bae JS. Collismycin C reduces HMGB1-mediated septic responses and improves survival rate in septic mice. J Asian Nat Prod Res. 2021 Jan;23(1):55-72. doi: 10.1080/10286020.2019.1706497. Epub 2019 Dec 31. PMID: 31888389.
7: Garcia I, Vior NM, Braña AF, González-Sabin J, Rohr J, Moris F, Méndez C, Salas JA. Elucidating the biosynthetic pathway for the polyketide-nonribosomal peptide collismycin A: mechanism for formation of the 2,2'-bipyridyl ring. Chem Biol. 2012 Mar 23;19(3):399-413. doi: 10.1016/j.chembiol.2012.01.014. PMID: 22444595.
8: Lee BS, Kim E, Choi H, Bae JS. Suppressive functions of collismycin C in TGFBIp-mediated septic responses. J Nat Med. 2020 Mar;74(2):387-398. doi: 10.1007/s11418-019-01374-9. Epub 2019 Nov 23. PMID: 31760555.
9: Lee JH, Kim E, Choi H, Lee J. Collismycin C from the Micronesian Marine Bacterium Streptomyces sp. MC025 Inhibits Staphylococcus aureus Biofilm Formation. Mar Drugs. 2017 Dec 12;15(12):387. doi: 10.3390/md15120387. PMID: 29231844; PMCID: PMC5742847.
10: Chen Z, Ou P, Liu L, Jin X. Anti-MRSA Activity of Actinomycin X2 and Collismycin A Produced by Streptomyces globisporus WA5-2-37 From the Intestinal Tract of American Cockroach (Periplaneta americana). Front Microbiol. 2020 Apr 7;11:555. doi: 10.3389/fmicb.2020.00555. PMID: 32318039; PMCID: PMC7154055.
11: Chen D, Zhao Q, Liu W. Discovery of caerulomycin/collismycin-type 2,2'-bipyridine natural products in the genomic era. J Ind Microbiol Biotechnol. 2019 Mar;46(3-4):459-468. doi: 10.1007/s10295-018-2092-7. Epub 2018 Nov 27. PMID: 30484122.
12: Sialer C, García I, González-Sabín J, Braña AF, Méndez C, Morís F, Salas JA. Generation by mutasynthesis of potential neuroprotectant derivatives of the bipyridyl collismycin A. Bioorg Med Chem Lett. 2013 Oct 15;23(20):5707-9. doi: 10.1016/j.bmcl.2013.08.017. Epub 2013 Aug 12. PMID: 23993774.
13: Ma Y, Guo P, Chen X, Xu M, Liu W, Jin X. Anti-Klebsiella pneumoniae activity of secondary metabolism of Achromobacter from the intestine of Periplaneta americana. BMC Microbiol. 2023 Jun 5;23(1):162. doi: 10.1186/s12866-023-02909-7. PMID: 37277707; PMCID: PMC10240788.
14: Ku SK, Jeong SY, Yang S, Kim KM, Choi H, Bae JS. Suppressive effects of collismycin C on polyphosphate-mediated vascular inflammatory responses. Fitoterapia. 2019 Apr;134:447-453. doi: 10.1016/j.fitote.2019.03.022. Epub 2019 Mar 23. PMID: 30914331.
15: Liu W, Li E, Liu L, Tian F, Luo X, Cai Y, Wang J, Jin X. Antifungal activity of compounds from Gordonia sp. WA8-44 isolated from the gut of Periplaneta americana and molecular docking studies. Heliyon. 2023 Jul 4;9(7):e17777. doi: 10.1016/j.heliyon.2023.e17777. PMID: 37539250; PMCID: PMC10395128.
16: Ma X, Tang Z, Ding W, Liu T, Yang D, Liu W, Ma M. Structure-Based Mechanistic Insights into ColB1, a Flavoprotein Functioning in-trans in the 2,2'-Bipyridine Assembly Line for Cysteine Dehydrogenation. ACS Chem Biol. 2023 Jan 20;18(1):18-24. doi: 10.1021/acschembio.2c00785. Epub 2023 Jan 5. PMID: 36603145.
17: Bu YY, Yamazaki H, Ukai K, Namikoshi M. Anti-mycobacterial nucleoside antibiotics from a marine-derived Streptomyces sp. TPU1236A. Mar Drugs. 2014 Dec 17;12(12):6102-12. doi: 10.3390/md12126102. PMID: 25522318; PMCID: PMC4278220.
18: Liang L, Haltli B, Marchbank DH, Fischer M, Kirby CW, Correa H, Clark TN, Gray CA, Kerr RG. Discovery of an Isothiazolinone-Containing Antitubercular Natural Product Levesquamide. J Org Chem. 2020 May 15;85(10):6450-6462. doi: 10.1021/acs.joc.0c00339. Epub 2020 May 4. PMID: 32363877.
19: Stadler M, Bauch F, Henkel T, Mühlbauer A, Müller H, Spaltmann F, Weber K. Antifungal actinomycete metabolites discovered in a differential cell-based screening using a recombinant TOPO1 deletion mutant strain. Arch Pharm (Weinheim). 2001 May;334(5):143-7. doi: 10.1002/1521-4184(200105)334:5<143::aid- ardp143>3.0.co;2-b. PMID: 11413818.
20: Shindo K, Yamagishi Y, Okada Y, Kawai H. Collismycins A and B, novel non- steroidal inhibitors of dexamethasone-glucocorticoid receptor binding. J Antibiot (Tokyo). 1994 Sep;47(9):1072-4. doi: 10.7164/antibiotics.47.1072. PMID: 7928696.